HMA - Heads of Medicines Agencies
  • RSS
  • Sitemap
  • Contact
  • About HMA
  • Human Medicines
  • Veterinary Medicines
  • You are here:
  • Home
  • >Human Medicines
  • CMDh
  • MRI Product Index
  • Pharmacovigilance
  • Availability of Medicines
  • Publications and reports
  • National Contacts

 

Human Medicines

This area of the website provides information relating to the regulation of human medicines, including access to product information, pharmacovigilance and the directory of relevant agencies.

HUMAN MEDICINES | RECENTLY PUBLISHED

Member: Sigridur KristinsdottirAlternate: Bryndís Ragnarsdóttir Icelandic…
modified 20/11/2026

ENANTONE LP and assiciated names (Leuprorelin acetate)End of procedure:…
added 19/11/2026

Leucrin PDS Depot (Leuprorelin acetate)End of procedure: 08/02/2025Date of…
modified 19/11/2026

Added in November 2026 19 November NEW - Art. 45 Public PdAR TetracosactideNEW…
modified 19/11/2026

Riamet (artemether / lumefantrine)UK/W/0096/pdWS/001End of procedure:…
modified 19/11/2026

TetracosactideEnd of procedure: 05/10/2026Date of publication: 19/11/2026
added 19/11/2026

MSs Recommendations on Extension Applications in Mutual Recognition and…
modified 19/11/2026

Information on nitrosamines for marketing authorisation holders
modified 19/11/2026

For additional specific information related to nationally authorised products…
modified 19/11/2026

CMDH PRESS RELEASES 2026
modified 18/11/2026

For the United Kingdom, as of 1 January 2021, European Union law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland / NI.

  • Useful Links
  • Privacy Policy
  • Credits & Disclaimer
  • Contact
© Heads of Medicines Agencies - https://www.hma.eu/human-medicines.html